Skip to main navigation Skip to search Skip to main content

Developing consensus on rare disease care pathways and ERN integration across Europe: insights from stakeholder workshops and a Delphi study

  • Augutė Juozapavičiūtė-Dvinelė*
  • , Michel W.P. Tsang-A-Sjoe*
  • , B.ZiemeleBaibaJA JARDIN WP6 collaborators
  • , Madara Auzenbaha
  • , Karolis Ažukaitis
  • , Birutė Tumienė
  • *Corresponding author for this work
  • Vilnius University
  • Amsterdam UMC
  • Children's Clinical University Hospital
  • Riga Stradins University
  • Institute of Health Information and Statistics of the Czech Republic
  • University Hospital Essen
  • CRMR SLA
  • University of Milan
  • University College Dublin
  • Spanish Kidney Patients Federation
  • Dutch Flemish Cystinosis Group-Cystinosis Network Europe
  • Patiëntenplatform Sarcomen
  • FEDER (Spanish Federation of Rare Diseases)
  • Radboud University Medical Center
  • Charles University
  • National and Kapodistrian University of Athens
  • Hospital Universitario La Paz
  • ULS Santa Maria
  • Reference Center of Inherited Metabolic Diseases
  • SJD Barcelona Children's Hospital
  • Tallaght University Hospital
  • DGO
  • Tartu University Hospital and Institute of Clinical Medicine
  • Skåne University Hospital
  • Patient representative
  • Children’s Health Ireland
  • Ljubljanski Univerzitetni Klinicni Center
  • National Institute of Health Doutor Ricardo Jorge (INSA)
  • Allianz
  • Institut Imagine
  • University Children's Hospital (Ljubljana)
  • Romanian Prader Willi Association
  • Université Paris Cité
  • Charitable Foundation “Orphanni Synytsi”
  • Center for Rare Diseases Mainz
  • Rare Diseases Greece
  • Ministry of Health
  • University of Amsterdam
  • Beaujon Hospital
  • European Reference Network (ERN) ‘Rare-Liver’

Research output: Contribution to journal › Article › Academic › peer-review

5 Downloads (Pure)

Abstract

Background:

Rare disease care pathways are complex and require coordination among specialised and non-specialised services, including genetic diagnostics, multidisciplinary expertise, and cross-border collaboration. Despite increasing policy attention and the establishment of European Reference Networks, the development and implementation of cohesive rare disease care pathways remain inconsistent across Europe. A shared, consensus-based framework reflecting stakeholder priorities is needed. 

Methods:

This exploratory study combined structured stakeholder workshops and a Delphi consensus process. Nine workshops were conducted within the JARDIN project, engaging stakeholders from 16 European countries. Data were collected using standardised Miro boards and analysed thematically using MAXQDA, guided by the SEIPS 2.0 framework. Insights from this analysis informed the development of statements, which were evaluated through a Delphi survey. Consensus was predefined as a median score of at least 4, an interquartile range (IQR) ≤1, and ≥80% agreement (ratings 4–5). 

Results:

A total of 216 individuals participated in the workshops, of whom 164 contributed during live sessions. Workshop data generated 1767 entries mapped across SEIPS domains. Seven thematic areas were identified: national strategy and governance; financing and sustainability; organisational structures and care coordination; access and equity; digital infrastructure and data systems; capacity building and education; and patient empowerment. Eighty-eight participants completed the Delphi survey, and consensus was achieved on all statements in the first round. 

Conclusion:

The findings demonstrate strong cross-country agreement on system-level requirements for effective rare disease care pathways. These consensus statements provide a structured framework for developing national care pathways and integrating European Reference Networks activities into routine healthcare systems.

Original languageEnglish
Article number105096
JournalEuropean Journal of Medical Genetics
Volume83
DOIs
Publication statusPublished - Sept 2026

Bibliographical note

Publisher Copyright:
© 2026 The Authors.

Fingerprint

Dive into the research topics of 'Developing consensus on rare disease care pathways and ERN integration across Europe: insights from stakeholder workshops and a Delphi study'. Together they form a unique fingerprint.

Cite this